Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000447358) titled 'ACE Trial: Assessing Cyproheptadine and Endep for treatment of vestibular migraine. A Randomised Controlled Trial' on April 10.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: Lauren Byrnes - Darling Downs Health
Condition:
Vestibular migraine
Vestibular migraine
Ear - Other ear disorders
Neurological - Other neurological disorders
Intervention:
Intervention arm 1: Cyproheptadine orally 2mg nocte for 2 nights, then 4mg orally nocte ongoing for 11 we...